SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-027585
Filing Date
2023-08-10
Accepted
2023-08-10 16:32:28
Documents
14
Period of Report
2023-08-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 53824
2 ex99-1.htm EX-99.1 13114
3 ex99-1_001.jpg GRAPHIC 3116
  Complete submission text file 0001493152-23-027585.txt   250302

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE xtnt-20230810.xsd EX-101.SCH 3027
5 XBRL LABEL FILE xtnt-20230810_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE xtnt-20230810_pre.xml EX-101.PRE 22367
8 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3268
Mailing Address 664 CRUISER LANE BELGRADE MT 59714
Business Address 664 CRUISER LANE BELGRADE MT 59714 406-388-0480
Xtant Medical Holdings, Inc. (Filer) CIK: 0001453593 (see all company filings)

IRS No.: 205313323 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34951 | Film No.: 231160098
SIC: 2836 Biological Products, (No Diagnostic Substances)